US 11229630
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted A61KA61K31/437A61K31/4545
Quick answer
US patent 11229630 (Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs) held by Olema Pharmaceuticals, Inc. expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Olema Pharmaceuticals, Inc.
- Grant date
- Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/4545, A61K31/475, A61K31/506